Alpha 1-antitrypsin and total trypsin-inhibitor capacity in acute pancreatitis
- PMID: 116590
Alpha 1-antitrypsin and total trypsin-inhibitor capacity in acute pancreatitis
Abstract
Twenty three patients with acute pancreatitis were studied to assess the serum alpha 1-antitrypsin levels as well as the total trypsin-inhibitor capacity. These parameters were found to be normal or increased, which is not the case with patients with chronic pancreatitis. The value of protease-inhibitor treatment in acute pancreatitis is doubted.
Similar articles
-
Serum immunoreactive trypsin and trypsin inhibitors during acute pancreatitis.Ann Chir Gynaecol. 1980;69(6):251-5. Ann Chir Gynaecol. 1980. PMID: 6163388
-
[Change in the trypsin-binding activity of alpha 2-macroglobulin and the general antitrypsin activity of the blood in chronic pancreatitis].Klin Med (Mosk). 1983 Nov;61(11):88-91. Klin Med (Mosk). 1983. PMID: 6198558 Russian. No abstract available.
-
[Role of bioantioxidants depression and deficiency of protease inhibitor alpha 1-antitrypsin in mechanisms activating free radical oxidation and proteolysis in chronic pancreatitis].Ter Arkh. 2000;72(2):29-31. Ter Arkh. 2000. PMID: 10717921 Clinical Trial. Russian.
-
Increased serum trypsinogen 2 and trypsin 2-1 antitrypsin complex values identify endoscopic retrograde cholangiopancreatography (ERCP)-induced pancreatitis with high accuracy.Gastrointest Endosc. 1998 Jun;47(6):554-5. Gastrointest Endosc. 1998. PMID: 9647391 Clinical Trial. No abstract available.
-
Protease inhibitors in acute human pancreatitis. Correlation between biochemical changes and clinical course.Scand J Gastroenterol. 1984 Sep;19(6):779-86. Scand J Gastroenterol. 1984. PMID: 6083596